VERA
insider transactionsVera Therapeutics, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 90d
-41.5K
0 buy · 41.5K sell
Net value · 90d
-$1.7M
$0 in · $1.7M out
Sentiment · 90d
Net selling
0% buying · 100% selling
Open-market trades · 90d
5
0 buy · 41.5K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
Director
$0
17.1K sh
Own New
-
Grant·A
Director
$0
17.1K sh
Own New
-
Grant·A
Director
$0
17.1K sh
Own New
-
Grant·A
Director
$0
17.1K sh
Own New
-
Grant·A
Director
$0
17.1K sh
Own New
-
Sell·S
Marshall Fordyce KEY
PRESIDENT AND CEO · 10b5-1
$158.8K
4.3K sh · $37.09
Own -2%
-
Sell·S
Marshall Fordyce KEY
PRESIDENT AND CEO · 10b5-1
$521.0K
14.2K sh · $36.64
Own -6%
-
Sell·S
Marshall Fordyce KEY
PRESIDENT AND CEO · 10b5-1
$41.0K
900 sh · $45.51
Own -0%
-
Sell·S
Marshall Fordyce KEY
PRESIDENT AND CEO · 10b5-1
$353.1K
7.9K sh · $44.58
Own -3%
-
Sell·S
Marshall Fordyce KEY
PRESIDENT AND CEO · 10b5-1
$617.0K
14.1K sh · $43.66
Own -5%
-
Grant·A
Director
$0
44.5K sh
Own New
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| May 21, 2026 | Christy J. Oliger | Grant A | 17.1K | $0 |
| May 21, 2026 | James R Meyers | Grant A | 17.1K | $0 |
| May 21, 2026 | Michael Morrissey | Grant A | 17.1K | $0 |
| May 21, 2026 | Kimball Hall | Grant A | 17.1K | $0 |
| May 21, 2026 | Andrew Cheng | Grant A | 17.1K | $0 |
| May 12, 2026 | Marshall Fordyce KEY 10b5-1 | Sell S | 4.3K | $158.8K |
| May 12, 2026 | Marshall Fordyce KEY 10b5-1 | Sell S | 14.2K | $521.0K |
| Apr 14, 2026 | Marshall Fordyce KEY 10b5-1 | Sell S | 900 | $41.0K |
| Apr 14, 2026 | Marshall Fordyce KEY 10b5-1 | Sell S | 7.9K | $353.1K |
| Apr 14, 2026 | Marshall Fordyce KEY 10b5-1 | Sell S | 14.1K | $617.0K |
| Apr 1, 2026 | Christy J. Oliger | Grant A | 44.5K | $0 |
About VERA insider trading
This page tracks insider transactions for Vera Therapeutics, Inc. (VERA) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.